Gesamtes Publikationsverzeichnis von PD Dr. Astrid Weyerbrock 1. Originalarbeiten: PD Dr. A. Weyerbrock a. Erst-/Seniorautor

IF 2012

1.

Weyerbrock A; Timmer J; Hohagen F; Berger M; Bauer J (1996). Effects of Light and Chronotherapy on human Circadian Rhythms in Delayed Sleep Phase Syndrome (DSPS): Cytokines, Cortisol, Growth Hormone and the Sleepwake Cycle. Biol Psychiatry, 40: 794-797.

9,247

2.

Weyerbrock A; Walbridge S; Pluta RM; Saavedra JE; Keefer KL; Oldfield EH (2003). Selective Opening of the Blood-tumor Barrier by a Nitric Oxide Donor and Long-term Survival in Rats with C6 Gliomas. J Neurosurg, 99(4): 728-737.

3,140

3.

Weyerbrock A; Baumer B; Papazoglou A (2009). Growth Inhibition and Chemosensitization of Exogenous Nitric Oxide released from NONOates in Glioma Cells in vitro. J Neurosurg, 110(1): 128-136.

3,140

4.

Deininger MH; Weyerbrock A (2009). Gravitational Valves in Supine Patients with Ventriculo-peritoneal Shunts. Acta Neurochir (Wien), 151 (6): 705-709.

1,546

5.

Weyerbrock A; Woznica M; Rosahl SK; Berlis A (2009). Aneurysmal and NonAneurysmal SAH - Is Initial Computed Tomography predictive? Fortschr Röntgenstr, 181: 881-887.

2,758

6.

Woznica M; Rosahl SK; Berlis A; Weyerbrock A (2010). Outcome correlates with blood distribution in subarachnoid hemorrhage of unknown origin. Acta Neurochir (Wien), 152: 417-422.

1,546

7.

Weyerbrock A; Walbridge S; Saavedra JE; Keefer LK; Oldfield EH (2011). Differential Effects of Nitric Oxide on Blood-Brain Barrier Integrity and Cerebral Blood Flow in Intracerebral C6 Gliomas. Neuro Oncol, 13(2): 203-11.

6,180

8.

Kogias E; Osterberg N; Baumer B; Psarras N; Koentges C; Papazoglou A; Saavedra JE; Keefer LK; Weyerbrock A (2011). Growth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-π activated nitric oxide donor PABA/NO in malignant gliomas. Int J Cancer, 130(5): 1184-94.

6,198

9.

Weyerbrock A; Osterberg N; Psarras N; Baumer B; Kogias E; Werres A; Bette S; Saavedra JE; Keefer LK; Papazoglou A (2011). JS-K, a Glutathione Stransferase-activated Nitric Oxide Donor with Antineoplastic Activity in Malignant Gliomas. Neurosurgery, 70(2): 497-510.

2,532

10.

Weidensteiner C, Reichardt W, Shami PJ, Saavedra JE, Keefer LK, Baumer B, Werres A, Jasinski R, Osterberg N, Weyerbrock A (2013). Effects of the nitric oxide donor JS-K on the blood-tumor barrier and on orthotopic U87 rat gliomas assessed by MRI., Nitric Oxide, 30: 17-25.

3,265

Publikationsverzeichnis PD Dr. A. Weyerbrock, 2013

b. Co-Autor 1.

Hohagen F; Timmer J; Weyerbrock A; Fritsch-Montero R; Ganter U; Krieger S; Berger M; Bauer J (1993). Cytokine Production during Sleep and Wakefulness and its Relationship to Cortisol in Healthy Humans. Neuropsychobiology, 28: 9-16.

2,371

2.

Warnke PC; Berlis A; Weyerbrock A; Ostertag CB (1997). Effect of LINAC Radiosurgery on Regional Cerebral Blood Flow, Glucose Metabolism and Sodium-Potassium ATPase in Skull Base Meningeomas and Metastasis. Acta Neurochir (Wien), 68: 124-126.

1,546

3.

Warnke PC; Berlis A; Weyerbrock A; Ostertag CB (1997). Significant Reduction of Seizure Incidence and Increase of Benzodiazepine Receptor Density after Interstitial Radiosurgery in Low-Grade. Acta Neurochir (Wien), 68: 90-92.

1,546

4.

Klisch J, Weyerbrock A, Spetzger U, Schumacher M (2003). Active Bleeding from Ruptured Cerebral Aneurysms during Diagnostic Angiography: Emergency Treatment. Am J Neuroradiol 24: 2062-65.

3,167

5.

Deininger MH; Wolter T; Weyerbrock A; Greulich A; Goldschmidt AJW (2006). Interdisciplinary Pain Therapy: An Innovative Therapeutic but Pre-DRG Economical Center of Medical Excellence. Cent Eur Neurosurg, 67: 67-75.

0,719

6.

Brawek B; Löffler M; Dooley DJ; Weyerbrock A; Feuerstein TJ (2008). Differential modulation of K+-evoked 3H-neurotransmitter release from human neocortex by gabapentin and pregabalin. Naunyn Schmiedebergs, Arch Pharmacol, 376: 301-307.

2,147

7.

Brawek B; Löffler M; Weyerbrock A; Feuerstein F (2009). Effects of gabapentin and pregabalin on K+-evoked 3H-GABA and 3H-glutamate release from human neocortical synaptosomes. Naunyn Schmiedebergs, Arch Pharmacol, 379 (4): 361-369.

2,147

8.

Mantovani M; Dooley DJ; Weyerbrock A; Jäckisch R; Feuerstein TJ (2009). Differential inhibitory effects of drugs acting at the norepinephrine and serotonin transporters in rat and human neocortical synaptosomes. Brit J Pharmacol, 158: 1848-1856.

5,067

9.

Brawek B; Löffler M; Wagner K; Huppertz HJ; Wendling AS; Weyerbrock A; Jäckisch R; Feuerstein TJ (2010). Reactive oxygen species (ROS) in human neocortex: Role of aging and cognition. Brain Res Bull, 81(4-5): 484-90.

2,935

10.

Keuler A; Weyerbrock A; Schumacher M (2010). Temporäre transvenöse Embolisation einer gigantischen arteriovenösen Fistel der Kopfhaut. Fortschr Röntgenstr, 182(4): 354-7.

2,758

11.

Bredel M; Scholtens DM; Yadav AK; Alvarez A; Renfrow JJ; Chandler JP; Yu IY; Carro MS; Tagge MJ; Ferrarese R; Bredel C; Phillips HS; Lukac PJ; Robe PA; Weyerbrock A; Vogel H; Dubner S; Mobley B; He Y; Scheck AC; Sikic BI; Aldape KD; Chakravarti A; Harsh GR (2011). NFKBIA Deletion in Glioblastomas. N Engl J Med, 364(7): 627-37.

51,658

Publikationsverzeichnis PD Dr. A. Weyerbrock, 2013

Firat E; Gaedicke S; Tsurumi C; Esser N; Weyerbrock A; Niedermann G (2011). Delayed cell death associated with mitotic catastrophe in gamma-irradiated stem-like glioma cells. Radiat Oncol, 6(1): 71. Firat E, Weyerbrock A, Gaedicke S, Grosu AL, Niedermann G. (2012). Chloroquine or Chloroquine-PI3K/Akt Pathway Inhibitor Combinations Strongly Promote γ-Irradiation-Induced Cell Death in Primary Stem-Like Glioma Cells, PLoS One, 7(10): e47357.

2,107

14.

Nguyen-Thanh T, Reisert M, Anastasopoulos C, Hamzei F, Reithmeier T, Vry MS, Kiselev VG, Weyerbrock A, Mader I (2013). Global Tracking in Human Gliomas: A Comparison with Established Tracking Methods. Clin Neuroradiol. 2013 Jan 18., 23(4): 263-275

1,379

15.

Kording F, Weidensteiner C, Zwick S, Osterberg N, Weyerbrock A, Staszewski O, Elverfeldt DV, Reichardt W. Simultaneous assessment of vessel size index, relative blood volume and vessel permeability in a mouse brain tumor model using a combined spin echo gradient echo echo-planar imaging sequence and viable tumor analysis. J Magn Reson Imaging2013 (in press)

2,566

12. 13.

Summe IF Originalarbeiten

3,730

126,096

2. Übersichtsarbeiten: PD Dr. A. Weyerbrock a. Erst-/Seniorautor 1.

Weyerbrock A; Oldfield EH (1999). Gene Transfer Technologies for Malignant Gliomas. Curr Opin Oncol, 11: 168-173.

IF 2012 4,027

b. Co-Autor 1.

Rutka JT; Weyerbrock A; Liang ML (2006). Glioma: Quo Vadis. Clinical Neurosurgery, 53:58-63.

Summe IF Übersichtsarbeiten

Publikationsverzeichnis PD Dr. A. Weyerbrock, 2013

n/a 4,027

3. Fallmitteilungen: PD Dr. A. Weyerbrock a. Erst-/Seniorautor 1.

IF 2012

Weyerbrock A, Mainprize T, Rutka JT (2006). Endoscopic Fenestration of a Symptomatic Cavum Septum Pellucidum: Technical Case Report. Neurosurgery, 59(4Suppl2): ONS-E491.

2,532

b. Co-Autor 1.

Lutterbach J, Pagenstecher A, Weyerbrock A, Schultze-Seemann W, Waller CF (2005). Early-stage penile carcinoma metastasizing to brain: case report and literature review. Urology 66(2): 432.

2,424

2.

Taschner C; Baumgartner S; Weyerbrock A; Hader C; Prinz M (2010). Freiburg Neuropathology Case Conference: a Diffusely Infiltrating Lesion. Klin Neuroradiol Feb 28 [epub ahead of print].

1,379

3.

Taschner C; Staszewski O; Weyerbrock A; Hader C; Prinz M (2011). Freiburg Neuropathology Case Conference: osteolytic lesion. Clin Neuroradiol, Apr, 21(1): 35-39.

1,379

4.

Taschner CA, Brendecke S, Weyerbrock A, Egger K, Prinz M (2012). Freiburg Neuropathology Case Conference: Widespread Mass Lesions After Resection of a Glioblastoma Multiforme, Clin Neuroradiol, 22(4):375-80.

1,379

Summe IF Fallmitteilungen

9,093

4. Buchbeiträge: PD Dr. A. Weyerbrock a. Erst-/Seniorautor 1.

Weyerbrock A; Oldfield EH (2000). Gene Therapy. In: Bernstein M, Berger M (eds.): NeuroOncology: the Essentials. Thieme (New York), 273-288. ISBN 0865778809.

b. Co-Autor

Publikationsverzeichnis PD Dr. A. Weyerbrock, 2013

-

5. Bücher: PD Dr. A. Weyerbrock a. Erst-/Seniorautor b. Co-Autor 1.

Seeger W, in collaboration with Rosahl SK, Warnke JP and Weyerbrock A (2006). Endoscopic Anatomy of the Third Ventricle: Microsurgical and Endoscopic Approaches. Springer (Wien), ISBN 3211311777.

2.

Seeger W, in collaboration with Kaminsky J and Weyerbrock A (2008). Endoscopic and microsurgical anatomy of the upper basal cisterns. Springer (Wien), ISBN 9783211770344.

3.

Seeger W, in collaboration with Kaminsky J and Weyerbrock A (2010). Endoscopic and microsurgical anatomy of the cranial base. Springer (Wien), ISBN 9783211993194.

6. Leserbriefe: PD Dr. A. Weyerbrock a. Erst-/Seniorautor 1.

Weyerbrock A, Oldfield EH (1998). Improving Drug Delivery to intracerebral Tumor and surrounding Brain in a Rodent Model: A Comparison of osmotic versus Bradykinin Modification of the Blood-brain barrier and/or Blood tumor Barriers – Comment. Neurosurgery, 43(4): 887-889.

b. Co-Autor -

Publikationsverzeichnis PD Dr. A. Weyerbrock, 2013

7. Publizierte Abstracts: PD Dr. A. Weyerbrock 1.

Warnke PC, Berlis A, Weyerbrock A, Ostertag CB (1996). Effect of LINAC radiosurgery on regional cerebral blood flow, glucose metabolism and sodium-potassium AtPase in skull base meningiomas and metastasis. European Society for Stereotactic and Functional Neurosurgery, Milano, 12.-15.06.1996. Acta Neurochir,138: 597-654.

2.

Warnke PC, Berlis A, Weyerbrock A, Ostertag CB (1996). Significant reduction of seizure incidence and increase of benzodiazepine receptor density after interstitial radiosurgery in low-grade gliomas. European Society for Stereotactic and Functional Neurosurgery, Milano, 12.-15.06.1996. Acta Neurochir, 138: 597-654.

3.

Koch D, Warnke PC, Weyerbrock A, Ostertag CB (1996). Changes in Regional Cerebral Blood Flow in Cavernomas – Effective Surgical Resection. European Society for Stereotactic and Functional Neurosurgery, Milano, 12.-15.06.1996. Acta Neurochir, 138: 597-654.

4.

Weyerbrock A, Walbridge S, Ramsey WJ, Oldfield EH (1998). Selective disruption of the blood-tumor barrier with a nitric oxide donor increases delivery of an adenoviral vector. J Neurooncol. 39(2): 140.

5.

Weyerbrock A, Walbridge S, Oldfield EH (1998). Intracarotid infusion of a nitric oxide donor selectively opens blood-tumor barrier in rat C6 tumors. J Neurooncol. 39(2): 160.

6.

Warnke PC, Weyerbrock A, Berlis A, Ostertag CB, Osborn C (1998). IV Cereport effect on cerebral metastases’ capillary permeability, vascular volume, extracellular space and blood flow. J Neurooncol. 39(2): 182.

7.

Weyerbrock A, Walbridge S, Ramsey WJ, Oldfield EH (1998). Selective disruption of the blood-tumor barrier with a nitric oxide donor increases delivery of an adenoviral vector. Acta Neurochir.140(8): 849.

8.

Weyerbrock A, Walbridge S, Oldfield EH (1998). Intracarotid infusion of a nitric oxide donor selectively opens blood-tumor barrier in rat C6 tumors. Acta Neurochir.140(8): 872.

9.

Warnke PC, Weyerbrock A, Ostertag CB (1998). Effect of the synthetic bradykinin Cereport on capillary permeability in untreated glioblastoma multiforme. Acta Neurochir.140(8): 872.

10.

Weyerbrock A, Walbridge S, Keefer KL, Oldfield EH (2000). Tumor-selective bloodbrain barrier disruption with a nitric oxide donor increases efficacy of intravenous carboplatin chemotherapy in rats with intracerebral C6 gliomas. Zentralbl Neurochir 61 Supplement 1: 38.

11.

Weyerbrock A, Walbridge S, Wildner O, Blaese MR, Oldfield EH (2000). Efficacy of replication-competent adenoviral vectors expressing the herpes simplex thymidine kinase gene for the treatment of malignant gliomas. Zentralbl Neurochir 61 Supplement 1: 42.

12.

Berlis A, Weyerbrock A, Spreer J, Klisch J, Schumacher M (2003). Differential endovascular treatment strategy of dissecting aneurysms of the vertebral artery. Neuroradiology 45 (Suppl1): 42-43.

Publikationsverzeichnis PD Dr. A. Weyerbrock, 2013

13.

Herrlinger U, Schäfer N, Steinbach JP, Weyerbrock A, Hau P, Goldbrunner R, Friedrich F, Stockhammer F, Ringel F, Braun C, Kohnen R, Leutgeb B, Belka C, Urbach H, Stummer W, Glas M. Bevacizumab, irinotecan and radiotherapy vs. standard temozolomide and radiotherapy in newly diagnosed MGMT-nonmethylated glioblastoma patients: First results from the randomized multicenter GLARIUS trial. J Clin Oncol 31, 2013 (suppl; abstr LBA2000).

14.

Stupp R., Hegi M.E., Gorlia T., Erridge S., Grujici D. , Steinbach J.P., Wick W., Tarnawiski R., Nam D. H., Weyerbrock A., Hau P., Taphoorn M.J.B., Nabors L.B., Reardon D. A., van den Bent M.J., Perry J.R., Hong Y.K., Hicking C., Picard M., Weller M., Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma and methylated O6-methylguanine-DNA methyltransferase (MGMT) gene promoter: Key results of the multicenter, randomized, open-label, controlled, phase III CENTRIC study. J Clin Oncol 31, 2013 (suppl; abstr LBA2009).

8. Nicht publizierte Vorträge: PD Dr. A. Weyerbrock 8.1. Vorträge auf Einladung a. Erst-/Seniorautor 1.

Weyerbrock A, Walbridge S, Boock RJ, Oldfield EH. Intracarotid infusion of a nitric oxide donor selectively opens blood-tumor barrier in rat C6 tumors. Congress of Neurological Surgeons, New Orleans, 27.09.-02.10.1997.

2.

Weyerbrock A, Walbridge S, Oldfield EH. Intracarotid infusion of a nitric oxide donor selectively opens blood-tumor barrier in rat C6 tumors. The Neurosurgical Society of the Virginias, Richmond, Virginia, 16.01.1998.

3.

Weyerbrock A, Walbridge S, Oldfield EH. Intracarotid infusion of a nitric oxide donor selectively opens blood-tumor barrier in rat C6 tumors. Cerebral Vascular Biology Conference 1998, Gleneden Beach, Oregon, 26.-28.03.1998.

4.

Weyerbrock A, Walbridge S, Ramsey WJ, Oldfield EH. Selective Disruption of the Blood-Tumor Barrier with a Nitric Oxide Donor Increases Delivery of an Adenoviral Vector. American Association of Neurological Surgeons, Philadelphia, 25.-30.04.1998.

5.

Weyerbrock A, Walbridge S, Oldfield EH. Delivery of an adenoviral vector into rat gliomas by blood-brain barrier disruption and by convection-enhanced delivery. The Neurosurgical Society of the Virginias, Hot Springs, Virginia, 15.01.1999.

6.

Weyerbrock A, Walbridge S, Keefer KL, Oldfield EH. Increased brain tumor microvessel permeability after administration of a nitric oxide donor in rat C6 tumors. American Association of Neurological Surgeons, New Orleans, 24.-29.04.1999.

7.

Weyerbrock A, Walbridge S, Wildner O, Blaese M, Oldfield EH. Replication-competent adenoviral vectors expressing the herpes simplex thymidine kinase gene: effficacy for the treatment of malignant gliomas. American Association of Neurological Surgeons, San Francisco, 08.-13.04.2000.

8.

Weyerbrock A, Walbridge S, Keefer KL, Oldfield EH. Tumor-selective blood-brain barrier disruption with a nitric oxide donor increases efficacy of intravenous carboplatin

Publikationsverzeichnis PD Dr. A. Weyerbrock, 2013

chemotherapy in rats with intracerebral C6 gliomas. American Association of Neurological Surgeons, San Francisco, 08.-13.04.2000. 9.

Weyerbrock A, Baumer B, Zentner J. Chronic subdural hematomoa: retrospective analysis of patients treated with twist-drill craniostomy and closed-system drainage. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Bielefeld, 27.-30.05.2001.

10.

Weyerbrock A, Walbridge S, Wildner O, Blaese M, Oldfield EH. Replication-competent adenoviral vectors expressing the herpes simplex thymidine kinase gene: effficacy for the treatment of malignant gliomas. Sektionstagung Neuroonkologie der DGNC, Halle/Saale, 07.08.12.2001.

11.

Weyerbrock A, Walbridge S, Keefer KL, Oldfield EH. Nitric Oxide Donor Selectively opens Blood-tumor Barrier and leads to Long-term Survival in Rats with C6 Gliomas. Sektionstagung Neuroonkologie der DGNC, Halle/Saale, 07.-08.12.2001.

12.

Weyerbrock A, Baumer B, Zentner J. Chronic subdural hematoma: clinical and radiological outcome of patients treated with twist-drill craniostomy and closed-system drainage. American Association of Neurological Surgeons, Chicago, 06.-11.04. 2002.

13.

Weyerbrock A, Baumer B, Klisch J, Spetzger U, Zentner J. Posthemorrhagic hydrocephalus after aneurysmal subarachnoid hemorrhage: analysis of factors influencing shuntdependency. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Halle/Saale, 02.05.06.2002.

14.

Weyerbrock A, Walbridge S, Keefer KL, Oldfield EH. Differential Effects of Nitric Oxide on Blood-brain Barrier Integrity and Cerebral Blood Flow in Intracerebral C6 Gliomas. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Halle/Saale, 02.-05.06.2002.

15.

Weyerbrock A, Baumer B, van Velthoven V. Age-related Outcome after Aneurysmal Subarachnoid Hemorrhage: Risks and Complications in Patients older than 70 years after Surgical and Endovascular Treatment. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Saarbrücken, 25.-28.05.2003.

16.

Weyerbrock A, Baumer B, van Velthoven V. Risk Factors influencing Outcome after Aneurysmal Subarachnoid Hemorrhage: Retrospective Analysis of Clinical Parameters after Surgical and Endovascular Treatment. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Saarbrücken, 25.-28.05.2003.

17.

Weyerbrock A, Baumer B, Papazoglou A, Zentner J. Effekte von NO auf C6-Gliomzellen. Sektionstagung Neuroonkologie der DGNC, München, 12.-13.12.2003.

18.

Weyerbrock A, Baumer B, Berlis A, van Velthoven V. Long-term Quality of Life of Elderly Patients after Aneurysmal Subarachnoid Hemorrhage. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Köln, 25.-28.04.2004.

19.

Weyerbrock A, Baumer B, Papazoglou A. Cytotoxic and Chemosensitizing Effects of NO in Glioma Cells in vitro. Sektionstagung Neuroonkologie der DGNC, Lübeck, 05.-06.11.2004.

20.

Weyerbrock A, Baumer B, Papazoglou A. JS-K, a glutathione S-transferase-activated nitric oxide donor with potent antineoplastic activity in malignant gliomas. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Leipzig, 26.-29.04.2007.

21.

Weyerbrock A; Baumer B; Kogias E; Papazoglou A. Antiproliferative activity of JS-K, a glutathione S-transferase-α activated nitric oxide donor in human glioblastomas in vitro.

Publikationsverzeichnis PD Dr. A. Weyerbrock, 2013

22.

Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Münster, 24.-27.5.2009. Weyerbrock A; Keuler A; Schumacher M. Transvenöse temporäre Embolisation einer gigantischen galealen AV-Fistel: eine präoperative Option. Sektionstagung Vaskuläre Neurochirurgie der Deutschen Gesellschaft für Neurochirurgie, Genf, 24.-25.4.2009.

23.

Weyerbrock A, Osterberg N, Ordikhani-Seyedlar M, Werres A, Weidensteiner C, Reichardt W. Impact of NO donor therapy with JS-K and temozolomide chemotherapy on tumor volume, perfusion and vascular permeability and survival in intracranial U87 xenografts in vivo. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Hamburg, 10.05.2011.

24.

Weyerbrock A, Verstärkt der Stickstoffmonoxid-Donor JS-K die Effekte von Sunitinib in Glioblastom-Stammzellen in vitro?. 63. Jahrestagung der DGNC, Leipzig, 15.06.12.

25.

Weyerbrock A, Osterberg N, Aravindalochanan K, Kieninger J, Urban G. „Development and evaluation of an electrochemical nitric oxide sensing onchip cell culture system for measurement of pericellular NO in glioma cell cultures”, 15. NOA-Jahrestagung der DKG, Münster, 06.07.2013.

b. Co-Autor 1.

Pluta R, Weyerbrock A, Boock RJ, Walbridge S, Oldfield EH. Opening of the Blood-Tumor Barrier With Intracarotid Delivery of Nitric Oxide Donor in Rat 9L Gliosarcoma. American Association of Neurological Surgeons, Philadelphia, 25.-30.04.1998.

2.

Berlis A, Weyerbrock A, Spreer J, Klisch J, Schumacher M. Differenzierte Behandlungsstrategie bei dissezierenden Vertebralisaneurysmen. Jahrestagung der Deutschen Gesellschaft für Neuroradiologie, Lübeck, 26.-28.08.2003.

3.

Weidensteiner C, Ordikhani-Seyedlar M, Werres A, Osterberg N, Weyerbrock A, Reichardt W. DCR-MRI in rat gliomas under therapy with temozolomide and a nitric oxide donor. Jahrestagung der International Society for Magnetic Resonance in Medicine (ISMRM). Montreal, 07.-13.05.2011.

4.

Bredel M, Scholtens A Yadav A, Renfrow J, Chandler J, Yu I, Carro M, Dai F, Tagge M, Ferrarese R, Bredel C, Phillips HS, Robe P, Weyerbrock A, Vogel H, Scheck A, Sikic BI, Aldape KD, Chakravarti A, Harsh G. NFKBIA deletion substitutes for EGFR amplification in glioblastoma pathogenesis. ASCO, Chicago, 03.-07.7.2011.

Publikationsverzeichnis PD Dr. A. Weyerbrock, 2013

8.2 Fortbildungsvorträge: PD Dr. A. Weyerbrock a. Erst-/Seniorautor 26.03.2002

„Pharmakogenetik“, Firma Genescan, Frankfurt

11.07.2002

„Konvektion und Blut-Hirn-Schranken-Öffnung als Mittel zur Optimierung der Behandlung maligner Gliome“, Neurobiologisches Kolloquium, LMU, München, Großhadern

05.11.2003

„Neurochirurgische Notfälle - Systematik aus chirurgischer Sicht“, Anästhesiologische Klinik, Universitätsklinik Freiburg

15.03.2004

„Schädel-Hirn-Trauma“, Department Universitätsklinik Freiburg

09.04.2005

„Cerebrale Tumore – Klassifizierung und Therapiestrategien“, Tumorzentrum der Universität Freiburg

07.05.2006

„Subarachnoidalblutung ohne Aneurysmanachweis“, Katharinenhospital Stuttgart, Neurochirurgische Klinik

25.09.2006

„Subarachnoidalblutung ohne Aneurysmanachweis“, Städtisches Klinikum Karlsruhe, Neurochirurgische Klinik

04.07.2007

„Qualitätsmanagement in der Neurochirurgie“, Neurochirurgische Universitätsklinik Frankfurt

16.11.2007

„Freiburger Erfahrungen mit Gliadel-Implantaten bei Glioblastomen“, GliadelAnwendertagung, Düsseldorf, 16.11.2007

30.05.2008

„Subarachnoidalblutung ohne Aneurysmanachweis, Symposium Neuromedizin, Erfurt

10.9.2009

„Bedeutung der Radikalität der Resektion beim Glioblastoma multiforme“, Symposium Gliome, Tumorzentrum Ludwig Heilmeyer, Freiburg

08.06.2011

„Operatives Vorgehen bei cerebralen Melanommetastasen“, Symposium Melanome, Tumorzentrum Ludwig Heilmeyer, Freiburg

08.06.2011

„Tumor Profiling – neue diagnostische Ansätze mit therapeutischer Relevanz? Veranstaltung zum Welthirntumortag 2011, Freiburg

21.11.2012

„Neurochirurgische Gliom-Therapie – zwischen Radikalität und Funktionserhaltung“, Update Neuronkologie, Klinik für Neurologie, Uniklinik Freiburg

04.05.2013

„Neurochirurgische Gliomtherapie – zwischen Radikalität und Funktionserhaltung“, 32. Hirntumorinformationstag der Deutschen Hirntumorhilfe, Frankfurt

20.06.2013

“Hirntumore – eine interdisziplinäre Herausforderung”, Zuweiserveranstaltung, Klinik für Neurochirurgie, Universitätsklinikum Freiburg

b. Co-Autor

Publikationsverzeichnis PD Dr. A. Weyerbrock, 2013

für

-

Orthopädie

und

Traumatolige,

9. Posterpräsentationen: PD Dr. A. Weyerbrock a. Erst-/Seniorautor 1.

Weyerbrock A, Wildner O, Walbridge S, Blaese M, Oldfield EH. Replication-competent adenoviral vectors expressing the herpes simplex thymidine kinase gene for the treatment of malignant gliomas. American Society for Gene Therapy Annual Meeting, Washington DC, 09.-13.06.1999.

2.

Weyerbrock A, Baumer B, Zentner J. Chronic subdural hematoma: retrospective analysis of patients treated with twist-drill craniostomy and closed-system drainage. Congress of Neurological Surgeons, San Diego, 29.09.-04.10.2001.

3.

Weyerbrock A, Walbridge S, Keefer KL, Oldfield EH. Differential Effects of Nitric Oxide on Blood-brain Barrier Integrity and Cerebral Blood Flow in Intracerebral C6 Gliomas. American Association of Neurological Surgeons, Chicago, 06.-11.04. 2002.

4.

Weyerbrock A, Baumer B, Papazoglou A, Zentner J. Nitric Oxide Effects on C6 Glioma Cells. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Köln, 25.-28.04.2004.

5.

Weyerbrock A, Baumer B, Papazoglou A. Modulation of Carboplatin chemotherapy and cytotoxicity of the nitric oxide donor Spermine-NO in glioma cells in vitro. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Strasbourg 07.-11.05.2005.

6.

Weyerbrock A, Baumer B, Berlis A, Rosahl SK. Subarachnoid Hemorrhage without Aneurysm on Angiogram: the Value of Repeat Angiography. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Strasbourg, 07.-11.05.2005.

7.

Weyerbrock A, Baumer B, Papazoglou A. JS-K, a glutathione S-transferase-activated nitric oxide donor, enhances imatinib (Glivec) cytotoxicity in malignant gliomas in vitro. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Leipzig, 26.-29.04.2007.

8.

Weyerbrock A; Baumer B; Kogias E; Papazoglou A. JS-K, a glutathione S-transferaseactivated nitric oxide donor with potent antineoplastic activity in malignant gliomas. NOATagung der Deutschen Krebsgesellschaft, Heidelberg, 25.-26.06.2009.

9.

Kogias E; Papazoglou A; Baumer B; Weyerbrock A. Growth-inhibition and chemosensitization to imatinib and carboplatin by the nitric oxide donor PABA/NO in U87 glioma cells in vitro. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Münster, 24.27.5.2009.

10.

Weyerbrock A; Psarras N; Baumer B; Kogias E; Papazoglou A. Attenuation of tumor growth and antiangiogenic effects of the nitric oxide donor JS-K in U87 gliomas in vivo. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Münster, 24.-27.5.2009.

11.

Thiede NK; Baumer B; Bette S; Weyerbrock A. NO donor JS-K enhances cytotoxic effects of radiotherapy in U87 gliomas in vitro. NOA-Tagung der Deutschen Krebsgesellschaft, Freiburg, 02.-03.07.2010.

12.

Weyerbrock A; Bette S; Werres A; Psarras N; Baumer B; Weidensteiner C; Reichardt W. NO donors in glioma therapy: can we improve the efficacy of temozolomide chemotherapy? Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Mannheim, 21.-25.9.2010.

Publikationsverzeichnis PD Dr. A. Weyerbrock, 2013

13.

Kogias E; Baumer B; Weyerbrock A. Enhancement of the growth-inhibitory effect of temozolomide by the nitric oxide donor PABA/NO in U87 glioma cells in vitro. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Mannheim, 21.-25.9.2010.

14.

Bette S; Baumer B; Weyerbrock A. Attenuation of cell motility and invasion by treatment of U87 glioma cells with the nitric oxide donor JS-K in vitro. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Mannheim, 21.-25.9.2010.

15.

Thiede NK; Baumer B; Osterberg N; Bette S; Weyerbrock A. NO donor JS-K enhances cytotoxic effects of radiotherapy in U87 gliomas in vitro. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Hamburg, 07.-11.05.2011.

16.

Heckler M; Osterberg N; Baumer B; Weyerbrock A. Nitric oxide donor JS-K intensifies cytotoxic effects of repetitive irradiation in U-87 glioma cells in vitro. Brain Tumor 2011, Berlin, 16.-17.06.2011.

17.

Osterberg N; Aravindalochanan K; Kieninger J; Urban G; Weyerbrock A. Entwicklung und Evaluation eines mikrochipbasierten elektrochemischen Stickstoffmonoxid (NO)-Sensors zur Messung von perizellulärem NO in Gliomzellkulturen, DGNC, Düsseldorf, 28.05.2013.

18.

Petö I; Beringer A; Scheiwe C; Weyerbrock A. Long-term outcome of medulloblastoma in adult population. Our experience with 2 patients, EANS Annual Meeting, Tel Aviv, 11.14.11.2013.

b. Co-Autor 1.

Brawek B; Donovan CM; Löffler M; Dooley DJ; Weyerbrock A; Feuerstein TJ. Gabapentin and pregabalin modulate K+-evoked [3H]-neurotransmitter release from discrete rat CNS regions and human neocortex. Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie, Mainz, 13.-15.3.2007.

2.

Brawek B; Weyerbrock A; Feuerstein TJ. Effects of the anticonvulsant drugs gabapentin and pregabalin on K+-evoked [3H]-GABA and [3H]-glutamate release from rat and human neocortical synaptosomes. Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie, Mainz, 11.-13.3.2008.

3.

Weidensteiner C; Ordikhani-Seyedlar M; Werres A; Osterberg N; Weyerbrock A; Reichardt W. DCR-MRI in rat gliomas under therapy with temozolomide and a nitric oxide donor. Jahrestagung der International Society for Magnetic Resonance in Medicine (ISMRM), Montreal, 07.-13.05.2011.

4.

Heckler M, Osterberg N, Weyerbrock A. Nitric Oxide Donor Produg JS-K increases Efficacy of repetitive Irradiation in U87 cell in vitro. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie, Leipzig, 13.-16.06.2012.

5.

Bredel M; Scholtens A Yadav A; Renfrow J; Chandler J; Yu I; Carro M; Dai F; Tagge M; Ferrarese R; Bredel C; Phillips HS; Robe P; Weyerbrock A; Vogel H; Scheck A; Sikic BI; Aldape KD; Chakravarti A; Harsh G. NFKBIA deletion substitutes for EGFR amplification in glioblastoma pathogenesis. ASCO, Chicago, 03.-07.7.2011.

6.

Baumgartner, C. Winkler, D. Wagner, N. von Bubnoff, S. Doostkam, A. Weyerbrock, M. Prinz, M. Lettau, J. Held, S. Poppert, M. Trippel, O. Stich. Zerebrale Echinokokkose als mögliche Differenzialdiagnose unklarer zerebraler Raumforderungen. DGN-Tagung, Dresden, 18-21.09.13.

Publikationsverzeichnis PD Dr. A. Weyerbrock, 2013

10. Sonstiges: PD Dr. A. Weyerbrock a. Erst-/Seniorautor 1.

Weyerbrock A. The ever mysterious brain. Public Service Review: European Union: issue 22, 2011.

2.

Weyerbrock A. Vom Labor zum Krankenbett. Management & Krankenhaus, Wiley-VCH Verlag GmbH & Co KGaA, GIT Verlag, Weinheim, 8/2013.

b. Co-Autor -

Stand: 12.12.2013

Publikationsverzeichnis PD Dr. A. Weyerbrock, 2013